The Cytomegalovirus (CMV) IgG and IgM antibody test is an essential diagnostic tool used to assess exposure to CMV, a prevalent virus causing infections of varying severity. This test is particularly significant in prenatal care, organ transplantation, and for immunocompromised patients. It detects two antibodies: IgM, indicating recent infection, and IgG, signifying past or recent infection. IgM antibodies appear early in infection but may be undetectable in some cases, while IgG antibodies persist long-term, providing immunity. Interpretation of results requires clinical context, as negative IgM may not rule out early infection, and positive IgM suggests recent infection. Negative IgG indicates susceptibility to infection. Special considerations include potential cross-reactivity and impaired immune responses in immunocompromised patients. The test employs multiplex flow immunoassay technology, requiring serum samples handled under specific conditions. Clinically, it aids in managing CMV risks in pregnant women, transplant recipients, and immunocompromised individuals, ensuring appropriate medical interventions.
The Cytomegalovirus (CMV) IgG and IgM antibody test is an essential diagnostic tool used to assess exposure to CMV, a prevalent virus causing infections of varying severity. This test is particularly significant in prenatal care, organ transplantation, and for immunocompromised patients. It detects two antibodies: IgM, indicating recent infection, and IgG, signifying past or recent infection. IgM antibodies appear early in infection but may be undetectable in some cases, while IgG antibodies persist long-term, providing immunity. Interpretation of results requires clinical context, as negative IgM may not rule out early infection, and positive IgM suggests recent infection. Negative IgG indicates susceptibility to infection. Special considerations include potential cross-reactivity and impaired immune responses in immunocompromised patients. The test employs multiplex flow immunoassay technology, requiring serum samples handled under specific conditions. Clinically, it aids in managing CMV risks in pregnant women, transplant recipients, and immunocompromised individuals, ensuring appropriate medical interventions.
The lowest price from the last 30 days: £34
Awaiting result:
One day
Collect material:
Blood
Prepare:
The CMV IgG and IgM antibody test is vital for diagnosing CMV exposure, especially in prenatal care, organ transplantation, and immunocompromised patients. It detects IgM and IgG antibodies, indicating recent or past infections. Key points include:
- Negative IgM: Suggests no active infection but doesn't rule out early infection.
- Positive IgM: Indicates recent infection, primary or reactivated.
- Negative IgG: Implies no prior exposure, increasing susceptibility.
- Equivocal Results: Require retesting for confirmation.
Special considerations involve early infection detection, immunocompromised patients, and potential cross-reactivity. Understanding these factors aids in effective CMV management.
The Clove IgE serum test is essential for diagnosing clove allergies. It identifies specific IgE antibodies, crucial for:
- Diagnosing clove allergy by confirming sensitization.
- Guiding immunotherapy decisions.
- Identifying allergens causing allergic reactions or anaphylaxis.
Test Process:
- Specimen Collection: Serum is drawn from a vein.
- Testing Method: Uses Fluorescence Enzyme Immunoassay (FEIA).
- Result Interpretation: IgE levels indicate allergy likelihood.
Limitations:
- Possible false positives.
- Results need clinical context.
Proper specimen handling ensures accurate results, aiding allergy management and prevention.
Understanding test results for the CMV IgG and IgM antibody test is crucial for accurate diagnosis and patient management. Here's a brief guide:
- Negative IgM Result: Suggests no acute infection, but early infection can't be ruled out.
- Positive IgM Result: Indicates recent infection; could be primary, reactivated, or reinfection.
- Negative IgG Result: Implies no prior exposure; patient is susceptible to infection.
- Equivocal Results: May require retesting in 7-14 days for confirmation.
Consider clinical context, potential cross-reactivity, and limitations in early infection detection.
The lowest price from the last 30 days: £34
What is GetLabTest.com?
How do I get started with GetLabTest.com?
What diseases can GetLabTest.com detect?
How do I prepare for testing with GetLabTest.com?
Can I speak with a doctor about my results?
Is testing with GetLabTest.com covered by insurance?
How long does it take to receive the test results?
Can I access my test results online?
Is my personal information kept confidential?
What if I have questions or concerns about my test results?